31 Tributyltin (TBT), a peroxisome proliferator-activated receptor γ (PPARγ)/retinoid X receptor 32 (RXR) ligand and founding member of the environmental obesogen chemical class, induces 33 adipocyte differentiation and suppresses bone formation. A growing number of environmental 34 PPARγ ligands are being identified. However, the potential for environmental PPARγ ligands to 35 induce adverse metabolic effects has been questioned because PPARγ is a therapeutic target in 36 treatment of type II diabetes. We evaluated the molecular consequences of TBT exposure during 37 bone marrow multipotent mesenchymal stromal cell (BM-MSC) differentiation in comparison to 38 rosiglitazone, a therapeutic PPARγ ligand, and LG100268, a synthetic RXR ligand. Mouse 39 primary BM-MSCs (female, C57BL/6J) undergoing bone differentiation were exposed to 40 maximally efficacious and human relevant concentrations of rosiglitazone (100 nM), LG100268 41 (100 nM) or TBT (80 nM) for 4 days. Gene expression was assessed using microarrays, and in 42 silico functional annotation was performed using pathway enrichment analysis approaches. 43 Pathways related to osteogenesis were downregulated by all three ligands, while pathways 44 related to adipogenesis were upregulated by rosiglitazone and TBT. However, pathways related 45 to mitochondrial biogenesis and brown-in-white (brite) adipocyte differentiation were more 46 significantly upregulated in rosiglitazone-treated than TBT-treated cells. The lack of induction of 47 genes involved in adipocyte energy dissipation by TBT was confirmed by an independent gene 48 expression analysis in BM-MSCs undergoing adipocyte differentiation and by analysis of a 49 publically available 3T3 L1 data set. Furthermore, rosiglitazone, but not TBT, induced 50 mitochondrial biogenesis. This study is the first to show that an environmental PPARγ ligand has 51 a limited capacity to induce health promoting activities of PPARγ. 52 highly potent PPARγ ligand, which induces differentiation of bone marrow and adipose-derived 76 multipotent stromal cells (MSCs) into adipocytes and suppresses bone formation (Baker et al. 77